Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Kyverna Therapeutics

Rare Disease news

Rare Diseases Today—April 23, 2026

This week’s Rare Diseases update highlights late-stage clinical progress,…

Cell_Gene_Therapy

Cell and Gene Therapy Today—April 23, 2026

This week’s Gene and Cell Therapy update highlights regulatory momentum,…

Neuroscience

Neuroscience Weekly News - October 1st 2025

🧠 This Week in Neuroscience: Alzheimer’s EC Nod, Huntington’s Breakthrough, MS…

Rare Disease news

Rare Diseases Weekly News - September 30th 2025

🧬 This Week in Rare Diseases: FDA Label Expansion, Accelerated Approvals, RNA…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Basata $21 million Series A
Respiratory Today—May 8, 2026
Vaccines Today—May 8, 2026
Public Health Today—May 8, 2026
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership

Tags

albuterol budesonide Autolus AVLAYAH Biomea Fusion Bunkerhill Health Cancer Research UK Cleerly LABS AI-QCT Crofelemer Crohn Disease CytoCell DeviceGuide DX-104 enterprise software FG-3246 Frontotemporal Dementia FS Crohn’s Google Cloud Govorestat Health Canada health IT Heart failure with mildly reduced ejection fraction Inluriyo Iptacopan MoGen Onclarity HPV Self-Collection Kit Partner Therapeutics pediatric ulcerative colitis PharmaSens Precigen precision prostate cancer Protein-Based COVID-19 Vaccine PsA QSIVA RIGHT SMART Standing In The Gaap Synucleinopathies targeted protein degradation theranostics Trastuzumab Pamirtecan uniQure urgent surgery Vanderbilt University Medical Center Voranigo Wales Diabetes Psychology Pathway

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Basata $21 million Series A
Respiratory Today—May 8, 2026
Vaccines Today—May 8, 2026
Public Health Today—May 8, 2026
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership

TAGS

albuterol budesonide Autolus AVLAYAH Biomea Fusion Bunkerhill Health Cancer Research UK Cleerly LABS AI-QCT Crofelemer Crohn Disease CytoCell DeviceGuide DX-104 enterprise software FG-3246 Frontotemporal Dementia FS Crohn’s Google Cloud Govorestat Health Canada health IT Heart failure with mildly reduced ejection fraction Inluriyo Iptacopan MoGen Onclarity HPV Self-Collection Kit Partner Therapeutics pediatric ulcerative colitis PharmaSens Precigen precision prostate cancer Protein-Based COVID-19 Vaccine PsA QSIVA RIGHT SMART Standing In The Gaap Synucleinopathies targeted protein degradation theranostics Trastuzumab Pamirtecan uniQure urgent surgery Vanderbilt University Medical Center Voranigo Wales Diabetes Psychology Pathway

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy